RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Endo International Stock

Endo International ROCE 2024

Endo International ROCE

-0.06

Ticker

ENDPQ

ISIN

IE00BJ3V9050

WKN

A1XE6M

In 2024, Endo International's return on capital employed (ROCE) was -0.06, a -7.24% increase from the -0.06 ROCE in the previous year.

Endo International Aktienanalyse

What does Endo International do?

Endo International PLC is a global pharmaceutical company based in Ireland, specializing in the development, manufacturing, and distribution of prescription medications. The company was founded in New York City in 1920 as a small narcotic business and has since undergone significant changes and expansion through mergers and acquisitions. Endo now has its headquarters in Dublin, Ireland and a diverse portfolio of prescription drugs in various therapeutic areas. The company's business model focuses on the development and marketing of innovative and generic pharmaceuticals, medical devices, and diagnostic solutions to improve global patient health. It operates in five segments: Branded Pharmaceuticals, Generics, International Pharmaceuticals, Urology, and Specialty Products. The Branded Pharmaceuticals segment includes a wide range of prescription drugs targeting various indications, including pain relievers, hormone therapies, gastrointestinal products, and oncology treatments. Some of Endo's well-known brands include Lidoderm, Voltaren, and Percocet. The Generics division produces and distributes a variety of generic medications under different brand names, utilizing synergies within its network to reduce manufacturing costs and pass savings on to customers. The International Pharmaceuticals unit is responsible for Endo's global business, maintaining partnerships and joint ventures with partners worldwide and expanding the company's portfolio into new regions and markets. The Urology segment offers a broad spectrum of products and services for urology, including surgical and non-surgical procedures. This includes the globally top-selling transurethral resection generator, the GreenLight Laser. Endo's Specialty Products segment manufactures devices and active ingredients for critical infrastructure used in medical research and development. This unit has heavily focused on developing innovative solutions for medical challenges in recent years. Overall, Endo holds approximately 1% market share of the global pharmaceutical market. To strengthen its competitive position, the company focuses on expanding its product portfolio, increasing efficiency, and reducing costs. Endo has a strong presence in the American and European markets and is also active in emerging economies. It follows a growth strategy that emphasizes the introduction of new and innovative products to further expand its existing segments and explore new business areas. In 2020, Endo employed over 3500 employees worldwide and generated approximately $2.5 billion in revenue. The company aims to solidify its position as a leading pharmaceutical company and expand its influence in the global market. Endo International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Endo International's Return on Capital Employed (ROCE)

Endo International's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Endo International's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Endo International's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Endo International’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Endo International stock

What is the ROCE (Return on Capital Employed) of Endo International this year?

The ROCE of Endo International is -0.06 undefined this year.

How has the ROCE (Return on Capital Employed) of Endo International developed compared to the previous year?

The ROCE of Endo International has increased by -7.24% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Endo International?

A high Return on Capital Employed (ROCE) indicates that Endo International has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Endo International?

A low ROCE (Return on Capital Employed) can indicate that Endo International has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Endo International impact the company?

An increase in the ROCE of Endo International can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Endo International affect the company?

A decrease in ROCE of Endo International can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Endo International?

Some factors that can affect Endo International's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Endo International so important for investors?

The ROCE of Endo International is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Endo International take to improve the ROCE?

To improve the ROCE, Endo International can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Endo International pay?

Over the past 12 months, Endo International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Endo International is expected to pay a dividend of 0 USD.

What is the dividend yield of Endo International?

The current dividend yield of Endo International is .

When does Endo International pay dividends?

Endo International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Endo International?

Endo International paid dividends every year for the past 0 years.

What is the dividend of Endo International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Endo International located?

Endo International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Endo International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Endo International from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Endo International pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Endo International in the year 2023?

In the year 2023, Endo International distributed 0 USD as dividends.

In which currency does Endo International pay out the dividend?

The dividends of Endo International are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Endo International

Our stock analysis for Endo International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Endo International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.